RJFSA
TARA icon

Raymond James Financial Services Advisors’s Protara Therapeutics TARA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-288
Closed -$5K – 2924
2019
Q2 		$5K Hold
288
– – ﹤0.01% 2833
2019
Q1 		$6K Buy
+288
New +$32.9K ﹤0.01% 2782
2018
Q4 		– Sell
-308
Closed -$24K – 2818
2018
Q3 		$24K Hold
308
– – ﹤0.01% 2753
2018
Q2 		$30K Hold
308
– – ﹤0.01% 2697
2018
Q1 		$31K Hold
308
– – ﹤0.01% 2467
2017
Q4 		$23K Sell
308
-100
-25% -$8.02K ﹤0.01% 2481
2017
Q3 		$33K Hold
408
– – ﹤0.01% 2482
2017
Q2 		$25K Buy
+408
New +$22.9K ﹤0.01% 2456

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Raymond James Financial Services Advisors's TARA Position: Q3 2019 in Review

Raymond James Financial Services Advisors sold out of Protara Therapeutics (TARA) in Q3 2019, closing a stake of 288 shares — an estimated $5K sold.

Raymond James Financial Services Advisors first reported a position in TARA in Q2 2017 and held it in 8 quarters. The position peaked at $33K in Q3 2017. 17 funds tracked by Wall St. Rank hold TARA as of Q3 2019.

  • Raymond James Financial Services Advisors reported no remaining Protara Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 288 Protara Therapeutics shares in Q3 2019, an estimated $5K.
  • Raymond James Financial Services Advisors first reported a position in Protara Therapeutics in Q2 2017 and held it in 8 quarters.
  • Raymond James Financial Services Advisors's Protara Therapeutics position peaked at $33K in Q3 2017.
  • 17 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2019, filed 7 Nov 2019.